Adenosine diphosphate (ADP) plays a critical role in platelet activation both by exogenous stimulation and the release of endogenous intracellular stores. As the platelet ADP receptor is not well defined, w e have chosen to identify and characterize several cell lines that possess functional receptors for this nucleotide. Rat promegakaryoblasts (RPM), human erythroleukemia cells (HEL), U937, and K562 leukemia cells responded to ADP, as measured by a rapid increase in intracellular calcium. A of platelet aggregation, and the subsequent release of endogenous platelet stores of ADP can lead to the irreversible phase of aggregation.' Currently, there is great variation in the published characteristics of putative platelet ADP receptors. Most studies suggest a single class of binding sites with the number of sites per platelet ranging from 400,000 to 4 10,000.*-' Dissociation constants (kd) have also vaned widely from relatively low affinity (7 pmol/L)' to high affinity (1 5 n m~l / L ) .~ Adler and Handin' obtained fourfold purification of a platelet membrane protein with a molecular weight of 6 1 Kd that possessed ADP-binding activity. However, studies using an ADP a n a l o g~e~.~,~~ showed the presence of four crosslinked polypeptides. It has been suggested that one of these polypeptides, a 100-Kd protein, may serve as an ADP receptor." Furthermore, Mills et al, have presented evidence for at least two distinct ADP receptors.12 Recently, Jefferson et a1 have synthesized a photoaffinity probe that is an ADP ana10gue.l~ Although six peptides bound to the probe were detected, unlabeled ADP could prevent binding to only three of them. Finally, there is data that suggest that ADP-induced calcium mobilization and shape change are mediated by different binding sites.I4 Clearly, these studies indicate that considerable uncertainty exists regarding the precise nature of the platelet ADP receptor. Our laboratory has approached this problem by using cultured cells with properties of hematopoietic progenitors. In addition to serving as a useful model for the examination of platelet-ligand interactions, these cell lines, in contrast to platelets, can be grown and maintained in large quantities. Finally, as opposed to anucleate platelets, these cell lines may play an important role in the study of the molecular biology of the ADP receptor.
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In the present study, we have demonstrated a functional receptor specific for ADP on the surface of these cultured cells. We believe that the delineation of the properties of this receptor on such cells can greatly aid in the study and purification of the ADP receptor on platelets.
MATERIALS AND METHODS
All cells were grown in suspension in 25 cmz tissue culture flasks at 37°C with 5% carbon dioxide in humidified air.
Media, serum, and antibiotics were purchased from GIBCO Laboratories (Grand Island, NY). Rat promegakaryoblasts (RPM), initially isolated by Cicoria et al," were obtained from Dr R. Rosenberg (Massachusetts Institute of Technology, Cambridge, MA). RPM cells were passaged I: 10 twice per week in RPMI 1640 supplemented with 10% fetal calf serum (FCS), 90 U/mL penicillin, and 90 pg/mL strep tomycin. Human erythroleukemia (HEL) cells, K562 cells (a chronic myelogenous leukemia cell line), and U937 (human histiocytic lymphoma) cells were purchased from American Type Culture Collection (ATCC; Rockville, MD) and were passaged weekly at a 1: 10 dilution and maintained in RPMI 1640 supplemented with 15% FCS, 86 U/ mL penicillin, and 86 pg/mL streptomycin. Cell counts were determined using a model ZF Coulter Counter (Coulter Electronics, Hialeah, FL). All experiments were performed during log phase growth.
Cells (5 X 10S/mL) were washed three times with Hank's Balanced Salt Solution (HBSS). The calciumsensitive dye, FURA-2 AM (Molecular Probes Inc, Eugene, OR),16 dissolved in dimethyl sulfoxide (DMSO) was added to the cell suspension at a final concentration of 1 pmol/L. After 20 minutes of incubation at 37°C excess probe was removed by extensive washing and the cells were resuspended at their original concentration in HBSS. A 3.0-mL aliquot of the cell suspension was placed in a polystyrene cuvette and the fluorescence was measured continuously using a LS-5B Luminescence Spectrometer (Perkin-Elmer, Nonvalk, CT). The excitation wavelength was set at 339 nm and the emission wavelength at 492 nm. The following platelet agonists (Sigma Chemical Co, St Louis, MO) were tested for their ability to stimulate Ca2+ flux under the above conditions: rat collagen, bovine collagen, epinephrine, ADP, and the calcium ionophore ionomycin. Human a-thrombin was a The fluorescence of a 3.0" sample was measured using a PerkinElmer LS-5B Luminescence Spectrometer. Platelet agonists were added to the cuvette and the change in intracellular calcium concentration was measured as described in the methods section. Values given are the means k SD of at least four separate determinations. 
mmol/L HEPES. Varying amounts of [3H]ADP (New England
Nuclear, Boston, MA) were added for 15 minutes at room temperature. Free labeled ligand was separated from bound ADP using a model M-24s cell washer and harvester (Brandel, Gaithersburg, MD). Cell pellets were counted in scintillation fluid in a LS 7800 liquid scintillation counter (Beckman Instruments, Fullerton, CA). To calculate specific binding, a parallel set of binding studies was run in the presence of a 100-fold excess of unlabeled ADP. Specific binding was defined as total binding less the binding in the presence of the excess unlabeled ligand. Adenosine and the following analogues (Sigma Chemical Co, St Louis, MO) were tested for their ability to inhibit binding of the labeled ADP to the cells: adenosine monophosphate (AMP), 5'-p-fluorosulfonylbenzoyladenosine (FSBA), 8-bromo ADP, periodate oxidized ADP, ATP, ADPPS, and ATPyS. All analogues were dissolved in THB except for FSBA, which was reconstituted in dimethylformamide (DMF). DMF concentration never exceeded 4%. The cells were first incubated with a 100-fold mol/L excess (except for FSBA, which was used at 100 pmol/L, or a 675-fold excess) of analogue for 15 minutes at room temperature. Subsequently, 148 nmol/L ['HIADP was added for an additional I5 minutes. After extensive washing, the cell pellets were harvested and counted as described above.
RESULTS

Ejects of platelet agonists on intracellular calcium.
Although a variety of known platelet agonists were tested using the RPM cell line, only ionomycin and ADP possessed For the ability to stimulate calcium mobilization ( Table I ). The responses were rapid, with the maximum intracellular calcium concentration ([Ca2'Ii) being reached in less than 10 seconds (Fig 1) . After an initial stimulus with ADP and an increase in intracellular free calcium, repetitive additions of ADP did not result in further increases in cytosolic calcium. The addition of thrombin, collagen, or epinephrine at the same concentrations shown in Table 1 did not result in detectable intracellular calcium mobilization within RPM cells (data not shown). Because the cytometnc studies analyze the response on a single-cell basis, these studies further showed that the response of RPM cells to ADP was homogeneous within the cell population.
The effect of varying cell number on the RPM-[3H]ADP interaction is shown in Fig 3. Initially, binding increased linearly with increasing numbers of cells, but at approximately 1.2 X lo7 cells/mL, the binding reached saturation.
The role of temperature with respect to the binding of labeled ADP to RPM cells was also examined. Binding was temperature dependent, as increasing the temperature of incubation from 4°C to 37°C caused a 129% enhancement of total binding and a 160% increment in specific binding (data not shown).
Furthermore, binding studies indicate that the specific binding of [3H]ADP to RPM, HEL, K562, and U937 cells is saturable (Fig 4) . Nonspecific binding, as determined by competition with unlabeled ADP, never accounted for more than 10% to 15% of total binding. Scatchard analysis'* of the binding data was used to calculate the kd and the number of Table 3 , of the four cell types examined, RPM cells have the greatest affinity for ADP with a kd of 7.75 X lo-' mol/L but the least number of binding sites per cell.
Finally, various structural analogues of ADP were used to study the inhibition of binding to the ADP receptor. As can be seen in Table 4 , ATP and ADP were the most potent inhibitors for all cell types resulting in an 80% to 95% decrease in binding. These inhibitory effects are comparable to those seen in mature platelets.' To ensure that ADP was not binding to adenosine receptors, which are widespread in biologic systems, unlabeled adenosine was also tested. This resulted in a modest (30%) inhibition with U937 cells and no significant inhibition in the binding of labeled ADP to the three other cell lines (Table 4 ).
DISCUSSION
ADP serves as an important mediator of platelet aggregation and may further amplify the aggregation process after the release of additional ADP from intraplatelet dense granules. However, the precise identity of the surface receptor by which platelets recognize ADP remains enigmatic. Our laboratory has used cultured cells with properties of hematopoietic progenitors as a model to study ADP-platelet interactions. The RPM cell is thought to be a very early precursor of megakaryocytes and platelets. Evidence that suggests this lineage includes the production of factor VI11 antigen," fibrinogen," acetylcholinesterase:' and a platelet factor 4 (PF4)-like protein. 20 Recently, Tayrien and Rosenberg*' have used the RPM cell in a PF4 stimulation assay for the purification of megakaryocyte stimulatory factor (MSF). HEL cells also may display characteristics of the megakaryocyte phenotype as evidenced by their reaction with monoclonal antibodies to glycoprotein (GP) Ib2' and GP IIbIIIa," proteins previously thought to be restricted to platelets and their precursors. Finally, because constitutive expression of platelet membrane glycoproteins has been shown in K562 cells, these cells also may demonstrate a megakaryocyte phen~type.'~ However, these cultured cells do not undergo shape change and aggregation, the usual responses to platelet activation. By using calcium flux as a measure of cell stimulation, we have devised a method for studying agonist-receptor relationships in these cells.
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Initially, the effect of a variety of known platelet agonists on the calcium mobilization of the RPM cell was studied. Previously, our laboratory demonstrated that radiolabeled human thrombin can specifically bind to RPM cells.24 Therefore, changes in intracellular calcium concentrations were measured to determine whether this binding results in a physiologic response. As Table 1 indicates, there was no response to thrombin even at extremely high concentrations under our experimental conditions. HEL and K562 cells responded to thrombin with increases in intracellular calcium of 183% and 5 I %, respectively (unpublished observations), suggesting that perhaps the activation by thrombin is species specific.
Interestingly, ionomycin and ADP were the only agents tested to effect an increase in cytosolic calcium in the rodent cells. Flow cytometric analysis of ADP-induced intracellular calcium mobilization in RPM cells revealed that there was homogeneity within the populations of cells examined. These results suggest that these cultured promegakaryocytic cells do not contain subpopulations of cells that differ in the signal transduction cascade that is activated following the ADP receptor-ligand interaction.
The cells that demonstrated a response to ADP were of hematopoietic lineage (Table 2) . It has been recognized over the past few years that most bone marrow (BM)-derived cells arise from totipotent stem cells that possess the ability to differentiate in several directions. Thus, the finding that ADP can stimulate calcium flux in cells other than platelets is not surprising and indicates that the acquisition of functional ADP receptors may be a relatively early event in cell differentiation. Furthermore, it appears to be conserved in leukemic transformation.
Binding studies using [3H]ADP were performed to further examine the ADP interaction with both rat (RPM) and human (HEL, U937, and K562) cells. As can be seen in Fig 4, the binding of [3H]ADP to these cells was saturable. Scatchard analysis (Table 3 ) revealed that although the number of binding sites per cell was approximately equivalent for the four cell types, RPM cell receptors possessed the greatest affinity for the ligand.
A classification system for distinguishing the purinoreceptors for adenosine, adenosine triphosphate (ATP), and ADP has evolved over the past decade. This specifies that P I receptors are selectively more responsive to adenosine, whereas P2 receptors preferentially respond to ATP and ADP.25 The P2 class is further subdivided into PZx, PZy, P2=, and P2T subclasses. The P2T subclass is present on the platelet membrane and is unique in that it is activated by ADP rather than ATP. The PZu subclass is found on a wider variety of cells and is stimulated by both ATP and ADP and their respective analogues ATPyS and ADP/3S.26 The fact that the binding of [3H]ADP to RPM cells in our study was inhibited by both ATPyS and ADPDS (Table 4) suggests the possibility that the ADP receptor on this cell is of the PZy subclass. However, the lack of response to high concentrations of ATP (Table 1 ) and the fact that the effect of ATPyS and ADPpS on P2T receptors is not well defined makes a clear distinction between these two subclasses on the RPM cell impossible until more detailed studies are performed.
Recently, it has been demonstrated that HEL cells can be induced to differentiate toward a more megakaryocytic phenotype with the tumor promoter phorbol myristate acetate (PMA).27 Based on these findings, we measured the binding of [3H]ADP to HEL cells before and after exposure to I nmol/ L PMA. No difference in affinity or receptor number was detected (unpublished observations). Thus, specific ADP receptors appear relatively early in the cellular differentiation of BM progenitor cells and are fully functional at this stage of development. Data from our studies on the RPM cell suggest that the ADP receptor may be the first functional platelet agonist receptor to appear on the surface of the differentiating cell. Whether these receptors play an important physiologic role before cellular maturation into peripheral blood platelets remains to be determined.
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